title: Successful treatment of post-transplant Epstein-Barr virus-related meningoencephalitis by intravenous rituximab monotherapy.
authors.forename: Roberto
authors.initials: R
authors.lastname: Crocchiolo
authors.forename: Joseph
authors.initials: J
authors.lastname: Ciccolini
authors.forename: Jean
authors.initials: J
authors.lastname: El-Cheikh
authors.forename: Sabine
authors.initials: S
authors.lastname: Fürst
authors.forename: Luca
authors.initials: L
authors.lastname: Castagna
authors.forename: Angela
authors.initials: A
authors.lastname: Granata
authors.forename: Claire
authors.initials: C
authors.lastname: Oudin
authors.forename: Samia
authors.initials: S
authors.lastname: Harbi
authors.forename: Raynier
authors.initials: R
authors.lastname: Devillier
authors.forename: Stevan
authors.initials: S
authors.lastname: Legall
authors.forename: David
authors.initials: D
authors.lastname: Ternant
authors.forename: Gilles
authors.initials: G
authors.lastname: Paintaud
authors.forename: Bruno
authors.initials: B
authors.lastname: Lacarelle
authors.forename: Didier
authors.initials: D
authors.lastname: Blaise
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001663:Bilirubin / Q000097:blood; D020031:Epstein-Barr Virus Infections / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D004854:Herpesvirus 4, Human / Q000235:genetics; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008590:Meningoencephalitis / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D000069283:Rituximab; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab; D001663:Bilirubin